Product
Episcleral Celecoxib
1 clinical trial
7 indications
Indication
Macular EdemaIndication
Radiation RetinopathyIndication
Retinal Vein OcclusionIndication
Epiretinal MembraneIndication
Commotio RetinaeIndication
VitritisClinical trial
Phase I Study of Sequestered Transscleral, Controlled-Release Celecoxib Delivered Via Episcleral Reservoir for Treatment of Macular Edema & Inflammatory Disorders of the Eye Posterior Pole Including Sclera, Choroid, Retina or VitreousStatus: Active (not recruiting), Estimated PCD: 2024-06-30